Amikacin 250 mg Injection – Brands in India, Manufacturer & PCD Franchise (Amiza-250)
Amikacin-250 mg (2 ml) Injection
PCD Pharma Franchise Supplier in India · Made at WHO-GMP Partner Units
Form: Injection
Class: Aminoglycoside Antibiotic
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
For chemists, distributors and doctors: Amiza-250 (amikacin 250 mg / 2 ml injection (IV/IM)) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
Our Amikacin-250 mg (2 ml) Injection Brand Options (1 option)
Trumac Healthcare supplies the following Amikacin-250 mg (2 ml) Injection brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Amikacin-250 mg (2 ml) Injection is made at WHO-GMP certified partner units and supplied by Trumac Healthcare for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Amikacin-250 mg (2 ml) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the critical care pharma franchise product list (PDF). Comparing companies? See the injectable PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.
Amikacin 250 mg injection Brands in India – Amiza-250 for PCD Franchise & Wholesale
Looking for amikacin 250 mg injection brands in India? Trumac Healthcare markets amikacin 250 mg injection as Amiza-250, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock across India. The aminoglycoside injection physicians and paediatricians use for serious hospital infections such as sepsis, pneumonia and urinary infections, often with a beta-lactam; 100 mg and 500 mg cover other doses.
It is part of the injectable & critical care PCD franchise range. Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners; no franchise fee, minimum first order ₹25,000.
Related brands
- Amiza-250 – Amikacin 250 mg / 2 ml Injection (IV/IM), 1 Vial of 2 ml (250 mg)
- Amiza-100 – Amikacin 100 mg / 2 ml Injection (IV/IM)
- Amiza-500 – Amikacin 500 mg / 2 ml Injection (IV/IM)
- Tobracam-80 – Tobramycin 80 mg Injection (Ampoule)
- Full range: injectable & critical care PCD franchise
Ways to work with us
- PCD pharma franchise – amikacin 250 mg injection under our brand on a monopoly basis for your area, with visual aids and promotional material
- Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
- Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation
How to start
- Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
- Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
- Confirm the order and pay by NEFT, RTGS or IMPS
- Goods are dispatched once payment reflects, with the docket number for tracking
Questions buyers ask
Which amikacin 250 mg injection brands are available in India for PCD franchise?
Amiza-250 from Trumac Healthcare, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis across India.
Do you supply amikacin 250 mg injection wholesale?
Yes, to distributors and stockists with a valid drug licence. Share quantity and location for the rate.
Which division is it part of?
The injectable & critical care division, which can be taken alone on monopoly for your district.
Can I get amikacin 250 mg injection under my own brand?
Share your brand name, pack and quantity on WhatsApp and we will confirm availability and send a quotation.
Enquiry: Share your amikacin 250 mg injection requirement – franchise or wholesale, with strength, quantity and location. WhatsApp +91 90416 77932.
Therapeutic Indications
- Serious gram-negative bacterial infections — septicaemia, complicated UTI
- Hospital-acquired pneumonia and ventilator-associated pneumonia
- Complicated intra-abdominal infections (with beta-lactam)
- Skin, soft tissue and post-surgical infections
- Empirical therapy in febrile neutropenia
- Adjunct in multi-drug-resistant tuberculosis
Mechanism of Action
Amikacin binds irreversibly to the 30S bacterial ribosomal subunit, causing mRNA misreading and inhibition of protein synthesis. The resulting non-functional proteins damage bacterial cell membranes, producing rapid bactericidal effect. Activity is concentration-dependent with a long post-antibiotic effect supporting once-daily dosing.
Dosage & Administration
- Adults: 15 mg/kg/day, typically given as a single daily dose by IM injection or slow IV infusion.
- Dose adjustment required in renal impairment based on serum levels.
- Treatment duration typically 7–10 days.
Side Effects
- Nephrotoxicity, ototoxicity (cochlear and vestibular), neuromuscular blockade.
- Local injection site pain.
- Less commonly: hypersensitivity, rash, transient hepatic enzyme elevation.
Contraindications
- Hypersensitivity to aminoglycosides.
- Concomitant nephrotoxic/ototoxic drugs without monitoring.
- Pre-existing 8th cranial nerve damage.
- Myasthenia gravis.
- Pregnancy (Category D).
- Therapeutic drug monitoring strongly advised in renal impairment.
Storage
Store below 25 °C, protected from light. Do not freeze.
PCD Pharma Franchise for Amikacin-250 mg (2 ml) Injection
- ✓ Made at WHO-GMP certified partner units
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: Vial
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Amikacin-250 mg (2 ml) Injection — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Amikacin-250 mg (2 ml) Injection, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Amikacin-250 mg (2 ml) Injection?
Trumac Healthcare markets Amikacin-250 mg (2 ml) Injection made at WHO-GMP certified partner manufacturing units in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Amikacin-250 mg (2 ml) Injection available for PCD pharma franchise on monopoly basis?
Yes. We offer Amikacin-250 mg (2 ml) Injection for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Amikacin-250 mg (2 ml) Injection?
Available pack sizes include: Vial.
What is the MRP / trade price for Amikacin-250 mg (2 ml) Injection?
MRPs range from ₹85 to ₹85 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Amikacin-250 mg (2 ml) Injection?
